CPHI Milan 2026: Natix backs microencapsulated enzymes for digestive and metabolic health
28 Oct 2026 | Natix
Stefaan Vandaele, CEO of Natix, noted that demand for plant- and animal-derived enzymes is rising, driven by interest in bioactives and the clean label trend — yet functionality remains essential. He highlighted the scientific backing for specific enzymes such as bromelain and papain. In digestive health, microencapsulation keeps enzymes effective through stomach acid, and Vandaele sees the category growing as the pharmaceutical and nutraceutical industries respond to demand for metabolic health.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement




















